Press Release April 11, 2023 Type 1 Diabetes Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook
Press Release April 11, 2023 Neurofibromatosis: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
Press Release April 11, 2023 Neurodermatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market|Key Companies Sanofi, Trevi Therapeutics, Galderma, Kiniksa Pharmaceuticals
Press Release April 11, 2023 Nephrotic Syndrome Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market Alderya Therapeutics, Roche, Astellas Pharmaceuticals, Novartis Pharmaceuticals, SynAct
Press Release April 11, 2023 Nephrosclerosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market | Companies-Astellas Pharmaceuticals, Alexion Pharmaceuticals
Press Release April 11, 2023 Opioid Induced Constipation(OIC) Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
Press Release April 11, 2023 70+ Active Companies working to develop 70+ Pipeline Therapies for Schizophrenia Treatment Landscape | Major Companies – Otsuka Pharmaceutical, Takeda, Vanda Pharmaceuticals, and Others
Press Release April 11, 2023 30+ Active Companies working to develop 35+ Pipeline Therapies for Food Allergy Treatment Landscape | Major Companies – Merck, Genentech, Novartis, and Others
Press Release April 11, 2023 80+ Active Companies working to develop 80+ Pipeline Therapies for Idiopathic Pulmonary Fibrosis Treatment Landscape | Major Companies – Roche, Novartis, Vicore Pharma, and Others.
Press Release April 11, 2023 100+ Active Companies working to develop 100+ Pipeline Therapies for Type 2 Diabetes Treatment Landscape | Major Companies – Hanmi Pharmaceuticals, Sanofi, AstraZeneca, and others